Brainsway (BWAY) Other Operating Expenses (2025 - 2026)

Brainsway posted quarterly Other Operating Expenses of $4.9 million for Q1 2026, up 18.45% year-on-year from $4.2 million in Q1 2025, and up 18.45% on a QoQ basis from $4.2 million in Q1 2025.

Brainsway (BWAY) has 2 years of Other Operating Expenses data on file, last reported at $4.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Operating Expenses rose 18.45% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $9.1 million (up 118.45% YoY), and the FY2025 full-year result was $18.9 million, up 16.85% from the prior year.
  • Other Operating Expenses for Q1 2026 stood at $4.9 million, up from $4.2 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $4.9 million in Q1 2026 and bottomed at $4.2 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Brainsway 6.80 Mn -52.98 Mn 11.68 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.93 Mn
Mar 31, 2025 4.16 Mn